Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases

Explore clinical trials studying Autoimmune Diseases. Study availability and eligibility vary by location and protocol.

10,826 public trials 1,644 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases trial results

Recruiting

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

NCT06133972

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group Llc Anniston, Alabama, United States
  • Providence Medical Center Burbank, California, United States
  • Advanced Medical Research La Palma, California, United States
  • Millennium Clinical Trials Westlake Village, California, United States
View all 143 locations
View Trial Details
Recruiting

A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus

NCT07509892

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • The First Affillated Hospital of Bengbu Medical Universit Bengbu, Anhui, China
  • Bozhou People's Hospital Bozhou, Anhui, China
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Southwest Hospital, Third Military Medical University (Army Medical University) Chongqing, Chongqing Municipality, China
View all 35 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

NCT06984627

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
Locations
  • Investigational Site Number : 1240003 Calgary, Alberta, Canada
  • Investigational Site Number : 1240002 Surrey, British Columbia, Canada
  • Investigational Site Number : 1240001 Sherbrooke, Quebec, Canada
  • Investigational Site Number : 2760002 Essen, Germany
View all 15 locations
View Trial Details
Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +13 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Barbara Davis Center for Diabetes Young Adult Clinic Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details

Related conditions